For the quarter ending 2025-09-30, CG had $959,900K increase in cash & cash equivalents over the period. -$2,137,800K in free cash flow.
| Cash Flow | 2025-09-30 |
|---|---|
| Net income | 599,200 |
| Depreciation and amortization | 143,100 |
| Equity-based compensation | 287,100 |
| Non-cash performance allocations and incentive fees, net | -13,100 |
| Non-cash principal investment income | 50,200 |
| Other non-cash amounts | -35,900 |
| Realized/unrealized (gain) loss on investments of consolidated funds | 100,100 |
| Realized/unrealized (gain) loss from loans payable of consolidated funds | 76,000 |
| Purchases of investments by consolidated funds | 8,990,300 |
| Proceeds from sales and settlements of investments by consolidated funds | 5,169,300 |
| Non-cash interest income, net | 13,000 |
| Change in cash and cash equivalents held at consolidated funds | -317,100 |
| Change in other receivables held at consolidated funds | 8,000 |
| Change in other liabilities held at consolidated funds | 65,300 |
| Purchases of investments | 251,100 |
| Proceeds from the sale of investments | 664,000 |
| Payments of contingent consideration | 2,700 |
| Changes in deferred taxes, net | 67,500 |
| Change in due from affiliates and other receivables | 8,700 |
| Change in deposits and other | 25,400 |
| Change in accounts payable, accrued expenses and other liabilities | 37,800 |
| Change in accrued compensation and benefits | -61,400 |
| Change in due to affiliates | 25,100 |
| Change in lease right-of-use assets and lease liabilities | -9,700 |
| Change in deferred revenue | 226,700 |
| Net cash used in operating activities | -2,080,400 |
| Purchases of corporate treasury investments | 0 |
| Proceeds from corporate treasury investments | 0 |
| Purchases of fixed assets, net | 57,400 |
| Net cash used in investing activities | -57,400 |
| Borrowings under credit facilities | 0 |
| Repayments under credit facilities | 0 |
| Issuance of 5.05 senior notes due 2035, net of financing costs | 792,900 |
| Payments on clo borrowings | 52,000 |
| Proceeds from clo borrowings, net of financing costs | 64,800 |
| Net borrowings on loans payable of consolidated funds | 2,755,100 |
| Dividends to common stockholders | 379,200 |
| Payment of deferred consideration for carlyle holdings units | 0 |
| Contributions from non-controlling interest holders | 599,100 |
| Distributions to non-controlling interest holders | 308,100 |
| Common shares repurchased and net share settlement of equity-based awards | 482,800 |
| Change in due to/from affiliates financing activities | -25,600 |
| Net cash provided by financing activities | 3,015,400 |
| Effect of foreign exchange rate changes | 82,300 |
| Increase (decrease) in cash, cash equivalents and restricted cash | 959,900 |
| Cash and cash equivalents at beginning of period | 1,266,500 |
| Cash and cash equivalents at end of period | 2,226,400 |
Carlyle Group Inc. (CG)
Carlyle Group Inc. (CG)